Veit Roessner Selected Research

Tic Disorders (Tic Disorder)

5/2022	Hair cortisol-a stress marker in children and adolescents with chronic tic disorders? A large European cross-sectional study.
1/2022	Lack of Association of Group A Streptococcal Infections and Onset of Tics: European Multicenter Tics in Children Study.
1/2019	European Multicentre Tics in Children Studies (EMTICS): protocol for two cohort studies to assess risk factors for tic onset and exacerbation in children and adolescents.
1/2019	Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders.
5/2013	Pharmacological treatment of tic disorders and Tourette Syndrome.
7/2012	[Therapy of tic disorders].
5/2006	[Therapy of chronic tic disorders].
11/2004	[Therapy of tic-disorders].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Veit Roessner Research Topics

Disease

21	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 03/2022 - 01/2004
14	Anorexia Nervosa 05/2022 - 02/2005
12	Tics (Tic) 05/2022 - 07/2006
8	Tic Disorders (Tic Disorder) 05/2022 - 11/2004
6	Tourette Syndrome (Tourette's Syndrome) 01/2021 - 04/2010
6	Mental Disorders (Mental Disorder) 01/2021 - 06/2015
5	Schizophrenia (Dementia Praecox) 03/2016 - 05/2007
4	Autism Spectrum Disorder 11/2021 - 04/2018
4	Weight Gain 01/2021 - 10/2014
4	Substance-Related Disorders (Drug Abuse) 01/2021 - 01/2020
3	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 11/2021 - 04/2018
3	Body Weight (Weight, Body) 01/2021 - 01/2018
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021 - 01/2020
2	Malnutrition (Nutritional Deficiencies) 12/2020 - 12/2018
1	Infections 01/2022
1	Starvation 01/2022
1	Obesity 12/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2021
1	Psychotic Disorders (Schizoaffective Disorder) 01/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Tuberous Sclerosis (Bourneville's Disease) 03/2019
1	Movement Disorders (Movement Disorder) 01/2019
1	Cushing Syndrome 01/2018
1	Cerebral Cortical Thinning 04/2016
1	Cognitive Dysfunction 04/2015
1	Genetic Predisposition to Disease (Genetic Predisposition) 11/2014
1	Feeding and Eating Disorders (Eating Disorder) 10/2014
1	Disease Progression 04/2010

Drug/Important Bio-Agent (IBA)

8	Pharmaceutical PreparationsIBA 01/2021 - 11/2004
7	Methylphenidate (Ritalin)FDA LinkGeneric 01/2019 - 01/2009
5	Risperidone (Risperdal Consta)FDA LinkGeneric 03/2022 - 11/2004
5	Antipsychotic Agents (Antipsychotics)IBA 01/2019 - 11/2004
5	Dopamine (Intropin)FDA LinkGeneric 04/2018 - 12/2007
4	Tiapride HydrochlorideIBA 03/2022 - 05/2013
4	Biomarkers (Surrogate Marker)IBA 12/2018 - 11/2014
3	Serotonin (5 Hydroxytryptamine)IBA 03/2022 - 01/2009
3	Clonidine (ST 155)FDA LinkGeneric 03/2022 - 05/2013
3	Aripiprazole (Abilify)FDA Link 01/2019 - 01/2018
2	Tryptophan (L-Tryptophan)FDA Link 05/2022 - 03/2022
2	Hydrocortisone (Cortisol)FDA LinkGeneric 05/2022 - 01/2018
2	Guanfacine (Tenex)FDA LinkGeneric 03/2022 - 01/2019
2	Neurotransmitter Agents (Neurotransmitter)IBA 11/2021 - 04/2018
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021 - 10/2014
2	TESIBA 01/2021 - 01/2020
2	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 01/2021 - 01/2021
2	1,2,3,4-tetrahydroisoquinolineIBA 01/2021 - 12/2007
2	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2020 - 12/2019
2	Sulpiride (neogama)IBA 01/2019 - 05/2013
2	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 05/2013 - 01/2004
1	tyramine-deoxysorbitolIBA 05/2022
1	Thyroid HormonesIBA 01/2022
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2022
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2022
1	Deoxyribonucleases (DNase)FDA Link 01/2022
1	streptolysin OIBA 01/2022
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2022
1	CholesterolIBA 12/2021
1	CeramidesIBA 12/2021
1	LipidsIBA 12/2021
1	Nerve Growth Factors (Neurotrophins)IBA 01/2021
1	EndocannabinoidsIBA 01/2021
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2021
1	tau Proteins (tau Protein)IBA 01/2021
1	peptide YY (3-36)IBA 12/2020
1	des-n-octanoyl ghrelinIBA 01/2020
1	GhrelinIBA 01/2020
1	Hormones (Hormone)IBA 01/2020
1	trans-sodium crocetinate (crocetin)IBA 03/2019
1	MTOR InhibitorsIBA 03/2019
1	ProlactinIBA 01/2019
1	Pimozide (Orap)FDA Link 01/2019
1	Topiramate (Topamax)FDA LinkGeneric 01/2019
1	Type A Botulinum Toxins (Botox)FDA Link 01/2019
1	Metoclopramide (Reglan)FDA LinkGeneric 01/2019
1	benzamideIBA 01/2019
1	Dronabinol (THC)FDA LinkGeneric 01/2019
1	ziprasidone (Geodon)FDA Link 01/2019
1	Haloperidol (Haldol)FDA LinkGeneric 01/2019
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2019
1	ningdongIBA 01/2019
1	AntigensIBA 01/2019
1	LeptinIBA 12/2018
1	Dopamine AntagonistsIBA 01/2018
1	BenzamidesIBA 01/2018
1	GuanineIBA 03/2016
1	CytosineIBA 03/2016
1	Biological ProductsIBA 03/2016
1	Peptides (Polypeptides)IBA 03/2016
1	Phosphates (Orthophosphate)IBA 03/2016
1	MicroRNAs (MicroRNA)IBA 06/2015
1	Nicotinamide PhosphoribosyltransferaseIBA 03/2015
1	NeurograninIBA 01/2013

Therapy/Procedure

12	Therapeutics 01/2022 - 11/2004
5	Neurofeedback 11/2020 - 04/2015
2	Complementary Therapies (Alternative Medicine) 10/2019 - 01/2019
2	Deep Brain Stimulation 01/2019 - 01/2019
2	Combined Modality Therapy 04/2016 - 11/2004
2	Transcranial Magnetic Stimulation 07/2012 - 04/2010
1	Behavior Control 11/2020
1	Injections 01/2019